Aug 9
|
Heron Therapeutics Inc (HRTX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...
|
Aug 8
|
Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
Aug 8
|
Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates
|
Aug 8
|
Heron Therapeutics Completes Capital Restructuring
|
Aug 8
|
Heron Therapeutics: Q2 Earnings Snapshot
|
Aug 8
|
Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile
|
Aug 8
|
Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress
|
Aug 8
|
Heron Therapeutics Reschedules Second Quarter 2025 Earnings Release and Conference Call to Friday, August 8, 2025
|
Jul 29
|
Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025
|
Mar 2
|
Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported Earnings, And Analysts Cut Their Target Price
|
Feb 28
|
High Growth Tech Stocks to Watch in US Market February 2025
|
Feb 28
|
Heron Therapeutics (NASDAQ:HRTX) shareholders are up 19% this past week, but still in the red over the last five years
|
Feb 28
|
Heron Therapeutics Full Year 2024 Earnings: Beats Expectations
|
Feb 28
|
Heron Therapeutics Inc (HRTX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...
|
Feb 28
|
Q4 2024 Heron Therapeutics Inc Earnings Call
|
Feb 27
|
Heron Therapeutics (HRTX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
|
Feb 27
|
Heron Therapeutics: Q4 Earnings Snapshot
|
Feb 27
|
Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates
|
Feb 13
|
Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025
|